AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 21

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.25 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020939SemaglutideWXTWXT-2508-G2836VendorInvestigate2025-Q397.763.1499.9Buyer-sourced1FAIL
AX-2025-020795BPC-157CPCCPC-2503-T9775Medutest2025-Q399.264.1594.8Buyer-sourced0PASS
AX-2025-019914PEG-MGFHJHJ-2507-S5943Medutest2025-Q398.147.59—Buyer-sourced0PASS
AX-2025-019264GHRP-6AMBAMB-2508-T5301VendorInvestigate2025-Q399.866.42—Buyer-sourced0PASS
AX-2025-020981PT-141 (Bremelanotide)WXTWXT-2507-R4042Nordanalyt2025-Q399.034.87105.2Buyer-sourced0PASS
AX-2025-019872SemaglutideHJHJ-2507-E6156VendorInvestigate2025-Q399.635.4488.9Buyer-sourced1MARGINAL
AX-2025-019011VilonASYASY-{CAT}-1626Medutest2025-Q399.938.97—Buyer-sourced1FAIL
AX-2025-018547PemvidutideQYBQYB-2502-V4343PeptideMeter2025-Q398.664.3691.0Buyer-sourced0PASS
AX-2025-018711AOD-9604QSCQSC-2508-B7258Kestrel2025-Q399.933.77—Buyer-sourced0PASS
AX-2025-020613SS-31 (Elamipretide)GL BiochemGLBI-2507-R8080VendorInvestigate2025-Q398.093.16100.8Buyer-sourced1FAIL
AX-2025-019836SemaglutideHomopeptideHOMO-2506-M5731Janoshik2025-Q398.066.2589.0Buyer-sourced2MARGINAL
AX-2025-020153IpamorelinERPERP-2502-S9437Medutest2025-Q399.003.0791.3Buyer-sourced0PASS
AX-2025-019873SemaglutideHJHJ-2507-E6156VendorInvestigate2025-Q399.835.23—Buyer-sourced0PASS
AX-2025-019689SelankTFCTFC-2504-G2332Medutest2025-Q399.247.8899.5Buyer-sourced1MARGINAL
AX-2025-019871SemaglutideHJHJ-2507-E6156Kestrel2025-Q399.934.9196.5Buyer-sourced1FAIL
AX-2025-020300MK-677 (Ibutamoren mesylate)GGPepsGGPE-2507-S2892Janoshik2025-Q399.844.9999.3Buyer-sourced0FAIL